The variants were heterozygous in GATM and GAMT, implying possible carrier status for a pathogenic mutation; and hemizygous for SLC6A8 in a single male, suggesting creatine transporter deficiency if the variant is proven pathogenic. This evidence concerns the gene GATM and hyperinsulinemic hypoglycemia, familial, 4.